# Anosmia and / or Ageusia and Early Corticosteroid Use

> **NCT04528329** · PHASE4 · UNKNOWN · sponsor: **ClinAmygate** · enrollment: 300 (estimated)

## Conditions studied

- Covid19
- Anosmia

## Interventions

- **DRUG:** Early-Dexamethasone
- **DRUG:** Late dexamethazone

## Key facts

- **NCT ID:** NCT04528329
- **Lead sponsor:** ClinAmygate
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-30
- **Primary completion:** 2023-11-01
- **Final completion:** 2023-12-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04528329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04528329, "Anosmia and / or Ageusia and Early Corticosteroid Use". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04528329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*